Header Logo

Connection

Sue Leurgans to Male

Back to Details
This is a "connection" page, showing publications Sue Leurgans has written about Male.
Sue Leurgans
Connection Strength
2.458
Male
  1. Joint modeling of missing data due to non-participation and death in longitudinal aging studies. Stat Med. 2010 Sep 20; 29(21):2260-8.
    View in: PubMed
    Score: 0.029
  2. Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegener Dis. 2010; 7(1-3):139-42.
    View in: PubMed
    Score: 0.028
  3. Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov Disord. 2009 Oct 15; 24(13):2015-9.
    View in: PubMed
    Score: 0.027
  4. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening. Mov Disord. 2008 Aug 15; 23(11):1541-5.
    View in: PubMed
    Score: 0.025
  5. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008 Apr 15; 23(5):690-9.
    View in: PubMed
    Score: 0.025
  6. Familial dysautonomia: frequent, prolonged and severe hypoxemia during wakefulness and sleep. Pediatr Pulmonol. 2008 Mar; 43(3):251-60.
    View in: PubMed
    Score: 0.025
  7. Effect of donepezil on motor and cognitive function in Huntington disease. Neurology. 2006 Oct 10; 67(7):1268-71.
    View in: PubMed
    Score: 0.022
  8. Does seasonal variation affect hallucinations in PD? A longitudinal study. Mov Disord. 2006 Jun; 21(6):863-5.
    View in: PubMed
    Score: 0.022
  9. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord. 2006 Feb; 21(2):267-70.
    View in: PubMed
    Score: 0.021
  10. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7.
    View in: PubMed
    Score: 0.021
  11. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology. 2005 Jan 11; 64(1):81-6.
    View in: PubMed
    Score: 0.020
  12. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology. 2003 Oct 14; 61(7):936-40.
    View in: PubMed
    Score: 0.018
  13. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci. 2003 Sep; 998:494-9.
    View in: PubMed
    Score: 0.018
  14. Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults. Neurology. 2023 08 15; 101(7):e754-e763.
    View in: PubMed
    Score: 0.018
  15. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023 04 01; 80(4):370-376.
    View in: PubMed
    Score: 0.017
  16. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.017
  17. Brain and spinal cord arteriolosclerosis and its associations with cerebrovascular disease risk factors in community-dwelling older adults. Acta Neuropathol. 2023 02; 145(2):219-233.
    View in: PubMed
    Score: 0.017
  18. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.017
  19. Self-reported fraud victimization and objectively measured blood pressure: Sex differences in post-fraud cardiovascular health. J Am Geriatr Soc. 2022 11; 70(11):3185-3194.
    View in: PubMed
    Score: 0.017
  20. A multicenter retrieval study of the taper interfaces of modular hip prostheses. Clin Orthop Relat Res. 2002 Aug; (401):149-61.
    View in: PubMed
    Score: 0.017
  21. Acute versus chronic inflammatory markers and cognition in older black adults: Results from the Minority Aging Research Study. Brain Behav Immun. 2022 07; 103:163-170.
    View in: PubMed
    Score: 0.016
  22. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open. 2022 04 04; 12(4):e059317.
    View in: PubMed
    Score: 0.016
  23. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.016
  24. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.016
  25. Dementia and autopsy-verified causes of death in racially-diverse older Brazilians. PLoS One. 2021; 16(12):e0261036.
    View in: PubMed
    Score: 0.016
  26. A pilot survey of African-American physician perceptions about clinical trials. J Natl Med Assoc. 2001 Dec; 93(12 Suppl):8S-13S.
    View in: PubMed
    Score: 0.016
  27. Associations of deformation-based brain morphometry with cognitive level and decline within older Blacks without dementia. Neurobiol Aging. 2022 03; 111:35-43.
    View in: PubMed
    Score: 0.016
  28. Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline. Stroke. 2022 01; 53(1):218-227.
    View in: PubMed
    Score: 0.016
  29. Physical activity, brain tissue microstructure, and cognition in older adults. PLoS One. 2021; 16(7):e0253484.
    View in: PubMed
    Score: 0.015
  30. Acculturation in Context: The Relationship Between Acculturation and Socioenvironmental Factors With Level of and Change in Cognition in Older Latinos. J Gerontol B Psychol Sci Soc Sci. 2021 03 14; 76(4):e129-e139.
    View in: PubMed
    Score: 0.015
  31. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease. PLoS One. 2021; 16(3):e0240342.
    View in: PubMed
    Score: 0.015
  32. Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample. Acta Neuropathol. 2021 05; 141(5):755-770.
    View in: PubMed
    Score: 0.015
  33. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.015
  34. Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults. PLoS One. 2021; 16(2):e0245680.
    View in: PubMed
    Score: 0.015
  35. Neuroticism, negative life events, and dementia in older White and Black Brazilians. Int J Geriatr Psychiatry. 2021 06; 36(6):901-908.
    View in: PubMed
    Score: 0.015
  36. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.015
  37. Latent Cognitive Class at Enrollment Predicts Future Cognitive Trajectories of Decline in a Community Sample of Older Adults. J Alzheimers Dis. 2021; 83(2):641-652.
    View in: PubMed
    Score: 0.015
  38. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.015
  39. Representation of Older Latinxs in Cohort Studies at the Rush Alzheimer's Disease Center. Neuroepidemiology. 2020; 54(5):404-418.
    View in: PubMed
    Score: 0.015
  40. Brain pathologies are associated with both the rate and variability of declining motor function in older adults. Acta Neuropathol. 2020 10; 140(4):587-589.
    View in: PubMed
    Score: 0.015
  41. Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults. Stroke. 2020 09; 51(9):2825-2833.
    View in: PubMed
    Score: 0.015
  42. Different Combinations of Mobility Metrics Derived From a Wearable Sensor Are Associated With Distinct Health Outcomes in Older Adults. J Gerontol A Biol Sci Med Sci. 2020 05 22; 75(6):1176-1183.
    View in: PubMed
    Score: 0.014
  43. Total daily physical activity, brain pathologies, and parkinsonism in older adults. PLoS One. 2020; 15(4):e0232404.
    View in: PubMed
    Score: 0.014
  44. Literacy Mediates Racial Differences in Financial and Healthcare Decision Making in Older Adults. J Am Geriatr Soc. 2020 06; 68(6):1279-1285.
    View in: PubMed
    Score: 0.014
  45. Dietary flavonols and risk of Alzheimer dementia. Neurology. 2020 04 21; 94(16):e1749-e1756.
    View in: PubMed
    Score: 0.014
  46. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46.
    View in: PubMed
    Score: 0.014
  47. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.014
  48. Proportion of cognitive loss attributable to terminal decline. Neurology. 2020 01 07; 94(1):e42-e50.
    View in: PubMed
    Score: 0.014
  49. A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med. 1999 Nov 04; 341(19):1426-31.
    View in: PubMed
    Score: 0.014
  50. Vocabulary comprehension in adults with fragile X syndrome (FXS). J Neurodev Disord. 2019 10 16; 11(1):25.
    View in: PubMed
    Score: 0.014
  51. Hip joint moments in symptomatic vs. asymptomatic people with mild radiographic hip osteoarthritis. J Biomech. 2019 Nov 11; 96:109347.
    View in: PubMed
    Score: 0.014
  52. Common age-related neuropathologies and yearly variability in cognition. Ann Clin Transl Neurol. 2019 11; 6(11):2140-2149.
    View in: PubMed
    Score: 0.014
  53. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.013
  54. Quantitative mobility metrics from a wearable sensor predict incident parkinsonism in older adults. Parkinsonism Relat Disord. 2019 08; 65:190-196.
    View in: PubMed
    Score: 0.013
  55. Expanding instrumented gait testing in the community setting: A portable, depth-sensing camera captures joint motion in older adults. PLoS One. 2019; 14(5):e0215995.
    View in: PubMed
    Score: 0.013
  56. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord. 1999 May; 14(3):502-6.
    View in: PubMed
    Score: 0.013
  57. Incident Mobility Disability, Mild Cognitive Impairment, and Mortality in Community-Dwelling Older Adults. Neuroepidemiology. 2019; 53(1-2):55-62.
    View in: PubMed
    Score: 0.013
  58. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology. 2019 04 16; 92(16):e1821-e1830.
    View in: PubMed
    Score: 0.013
  59. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.013
  60. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol Aging. 2019 05; 77:104-111.
    View in: PubMed
    Score: 0.013
  61. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.013
  62. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019 02 19; 92(8):e811-e822.
    View in: PubMed
    Score: 0.013
  63. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord. 1999 Jan; 14(1):117-21.
    View in: PubMed
    Score: 0.013
  64. Statistical Methodology for Multiclass Classifications: Applications to Dementia. J Alzheimers Dis. 2019; 68(1):173-186.
    View in: PubMed
    Score: 0.013
  65. Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diet Slows Cognitive Decline After Stroke. J Prev Alzheimers Dis. 2019; 6(4):267-273.
    View in: PubMed
    Score: 0.013
  66. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
    View in: PubMed
    Score: 0.013
  67. Spinal motor neurons and motor function in older adults. J Neurol. 2019 Jan; 266(1):174-182.
    View in: PubMed
    Score: 0.013
  68. Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns. J Gerontol A Biol Sci Med Sci. 2018 11 10; 73(12):1688-1694.
    View in: PubMed
    Score: 0.013
  69. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
    View in: PubMed
    Score: 0.012
  70. Effects of Fish Oil on HIV-Related Inflammation and Markers of Immunosenescence: A Randomized Clinical Trial. J Altern Complement Med. 2018 Jul; 24(7):709-716.
    View in: PubMed
    Score: 0.012
  71. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.012
  72. Association Between Quantitative Gait and Balance Measures and Total Daily Physical Activity in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2018 04 17; 73(5):636-642.
    View in: PubMed
    Score: 0.012
  73. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.012
  74. Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age. Neurobiol Dis. 2018 06; 114:31-44.
    View in: PubMed
    Score: 0.012
  75. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.012
  76. Ex-vivo quantitative susceptibility mapping of human brain hemispheres. PLoS One. 2017; 12(12):e0188395.
    View in: PubMed
    Score: 0.012
  77. Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson's disease. Brain Pathol. 2018 07; 28(4):560-568.
    View in: PubMed
    Score: 0.012
  78. Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism. Stroke. 2017 10; 48(10):2792-2798.
    View in: PubMed
    Score: 0.012
  79. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
    View in: PubMed
    Score: 0.012
  80. Urinary Incontinence, Incident Parkinsonism, and Parkinson's Disease Pathology in Older Adults. J Gerontol A Biol Sci Med Sci. 2017 Sep 01; 72(9):1295-1301.
    View in: PubMed
    Score: 0.012
  81. Decline in Literacy and Incident AD Dementia Among Community-Dwelling Older Persons. J Aging Health. 2018 10; 30(9):1389-1405.
    View in: PubMed
    Score: 0.012
  82. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.011
  83. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol. 2017 May; 38(5):961-965.
    View in: PubMed
    Score: 0.011
  84. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.011
  85. Association of cognitive activity and neurocognitive function in blacks and whites with HIV. AIDS. 2017 01 28; 31(3):437-441.
    View in: PubMed
    Score: 0.011
  86. Loneliness in Older Black Adults with Human Immunodeficiency Virus Is Associated with Poorer Cognition. Gerontology. 2017; 63(3):253-262.
    View in: PubMed
    Score: 0.011
  87. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.011
  88. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.011
  89. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int. 1996 Nov; 50(5):1641-50.
    View in: PubMed
    Score: 0.011
  90. Self-Reported Sleep in Older African Americans and White Americans. Ethn Dis. 2016 Oct 20; 26(4):521-528.
    View in: PubMed
    Score: 0.011
  91. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016 09 01; 73(9):1062-9.
    View in: PubMed
    Score: 0.011
  92. Incident parkinsonism in older adults without Parkinson disease. Neurology. 2016 Sep 06; 87(10):1036-44.
    View in: PubMed
    Score: 0.011
  93. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.011
  94. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.011
  95. Sigmoidal mixed models for longitudinal data. Stat Methods Med Res. 2018 03; 27(3):863-875.
    View in: PubMed
    Score: 0.011
  96. The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol. 2017 01; 27(1):77-85.
    View in: PubMed
    Score: 0.011
  97. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.011
  98. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.010
  99. Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology. J Gerontol A Biol Sci Med Sci. 2016 Apr; 71(4):549-56.
    View in: PubMed
    Score: 0.010
  100. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.010
  101. Change in motor function and adverse health outcomes in older African-Americans. Exp Gerontol. 2015 Oct; 70:71-7.
    View in: PubMed
    Score: 0.010
  102. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.010
  103. Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial. Mov Disord. 2015 Oct; 30(12):1657-63.
    View in: PubMed
    Score: 0.010
  104. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol. 2015 Oct; 67:58-64.
    View in: PubMed
    Score: 0.010
  105. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):942-52.
    View in: PubMed
    Score: 0.010
  106. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.010
  107. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016 05; 221(4):2135-46.
    View in: PubMed
    Score: 0.010
  108. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015 Mar 31; 84(13):1294-300.
    View in: PubMed
    Score: 0.010
  109. Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial. J Am Soc Nephrol. 1995 Mar; 5(9):1684-8.
    View in: PubMed
    Score: 0.010
  110. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
    View in: PubMed
    Score: 0.010
  111. Negative social interactions and risk of mild cognitive impairment in old age. Neuropsychology. 2015 Jul; 29(4):561-70.
    View in: PubMed
    Score: 0.010
  112. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.010
  113. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome? Clin Orthop Relat Res. 2015 Feb; 473(2):706-15.
    View in: PubMed
    Score: 0.010
  114. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people. Circulation. 2015 Jan 13; 131(2):182-9.
    View in: PubMed
    Score: 0.010
  115. Author response. Neurology. 2014 Sep 30; 83(14):1302.
    View in: PubMed
    Score: 0.010
  116. Industrial wrist motions and incidence of hand/wrist cumulative trauma disorders. Ergonomics. 1994 Sep; 37(9):1449-59.
    View in: PubMed
    Score: 0.010
  117. Two-year exercise program improves physical function in Parkinson's disease: the PRET-PD randomized clinical trial. Neurorehabil Neural Repair. 2015 Feb; 29(2):112-22.
    View in: PubMed
    Score: 0.010
  118. Cortical pyroglutamate amyloid-? levels and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36(1):12-9.
    View in: PubMed
    Score: 0.010
  119. Financial literacy is associated with medial brain region functional connectivity in old age. Arch Gerontol Geriatr. 2014 Sep-Oct; 59(2):429-38.
    View in: PubMed
    Score: 0.009
  120. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.009
  121. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014 Mar 25; 82(12):1045-50.
    View in: PubMed
    Score: 0.009
  122. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.009
  123. Associations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adults. PLoS One. 2014; 9(1):e86262.
    View in: PubMed
    Score: 0.009
  124. Reply to Itzhaki and Klapper. J Infect Dis. 2014 Mar; 209(6):974.
    View in: PubMed
    Score: 0.009
  125. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.009
  126. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.009
  127. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct. 2014 Nov; 219(6):2029-49.
    View in: PubMed
    Score: 0.009
  128. Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013; 8(5):e64111.
    View in: PubMed
    Score: 0.009
  129. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord. 2013 Nov; 28(13):1816-22.
    View in: PubMed
    Score: 0.009
  130. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.009
  131. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.009
  132. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord. 2013 Aug; 28(9):1230-40.
    View in: PubMed
    Score: 0.009
  133. Sleep complaints and incident disability in a community-based cohort study of older persons. Am J Geriatr Psychiatry. 2014 Jul; 22(7):718-26.
    View in: PubMed
    Score: 0.009
  134. Ex vivo MR volumetry of human brain hemispheres. Magn Reson Med. 2014 Jan; 71(1):364-74.
    View in: PubMed
    Score: 0.009
  135. Neuroticism, extraversion, and motor function in community-dwelling older persons. Am J Geriatr Psychiatry. 2013 Feb; 21(2):145-54.
    View in: PubMed
    Score: 0.009
  136. Neuroticism modifies the association of vision impairment and cognition among community-dwelling older adults. Neuroepidemiology. 2013; 40(2):142-6.
    View in: PubMed
    Score: 0.009
  137. Hippocampal proNGF signaling pathways and ?-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2012 Nov; 71(11):1018-29.
    View in: PubMed
    Score: 0.008
  138. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.008
  139. Association of total daily physical activity with disability in community-dwelling older persons: a prospective cohort study. BMC Geriatr. 2012 Oct 16; 12:63.
    View in: PubMed
    Score: 0.008
  140. Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease. Mov Disord. 2012 Nov; 27(13):1625-31.
    View in: PubMed
    Score: 0.008
  141. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.008
  142. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.008
  143. Effects of serial sectioning and repair of radial tears in the lateral meniscus. Am J Sports Med. 2012 Aug; 40(8):1863-70.
    View in: PubMed
    Score: 0.008
  144. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry. 2012 May 15; 2:e114.
    View in: PubMed
    Score: 0.008
  145. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
    View in: PubMed
    Score: 0.008
  146. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.008
  147. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep. 2012 May 01; 35(5):633-40B.
    View in: PubMed
    Score: 0.008
  148. Relation of driving status to incident life space constriction in community-dwelling older persons: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2012 Sep; 67(9):984-9.
    View in: PubMed
    Score: 0.008
  149. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol. 2012 Feb; 71(2):258-66.
    View in: PubMed
    Score: 0.008
  150. Association of lower hemoglobin level and neuropathology in community-dwelling older persons. J Alzheimers Dis. 2012; 32(3):579-86.
    View in: PubMed
    Score: 0.008
  151. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell. 2012 Apr; 11(2):228-33.
    View in: PubMed
    Score: 0.008
  152. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.008
  153. Quantification of the fragmentation of rest-activity patterns in elderly individuals using a state transition analysis. Sleep. 2011 Nov 01; 34(11):1569-81.
    View in: PubMed
    Score: 0.008
  154. Functional connectivity variations in mild cognitive impairment: associations with cognitive function. J Int Neuropsychol Soc. 2012 Jan; 18(1):39-48.
    View in: PubMed
    Score: 0.008
  155. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke. 2011 Nov; 42(11):3183-9.
    View in: PubMed
    Score: 0.008
  156. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.008
  157. Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am J Geriatr Psychiatry. 2011 Jun; 19(6):571-80.
    View in: PubMed
    Score: 0.008
  158. Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study. BMC Med. 2011 Apr 20; 9:42.
    View in: PubMed
    Score: 0.008
  159. Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations. Mov Disord. 2011 Aug 01; 26(9):1781-2.
    View in: PubMed
    Score: 0.008
  160. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.008
  161. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.008
  162. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.007
  163. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.007
  164. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 2011 Jan; 7(1):74-9.
    View in: PubMed
    Score: 0.007
  165. Loneliness and the rate of motor decline in old age: the Rush Memory and Aging Project, a community-based cohort study. BMC Geriatr. 2010 Oct 22; 10:77.
    View in: PubMed
    Score: 0.007
  166. Musculoskeletal pain is associated with incident mobility disability in community-dwelling elders. J Gerontol A Biol Sci Med Sci. 2011 Jan; 66(1):82-8.
    View in: PubMed
    Score: 0.007
  167. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.007
  168. Musculoskeletal pain and incident disability in community-dwelling older adults. Arthritis Care Res (Hoboken). 2010 Sep; 62(9):1287-93.
    View in: PubMed
    Score: 0.007
  169. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.007
  170. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry. 2010 May; 67(5):448-57.
    View in: PubMed
    Score: 0.007
  171. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord. 2010 Feb 15; 25(3):401-4.
    View in: PubMed
    Score: 0.007
  172. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc. 2010 Feb; 58(2):248-55.
    View in: PubMed
    Score: 0.007
  173. Congenital central hypoventilation syndrome: neurocognitive functioning in school age children. Pediatr Pulmonol. 2010 Jan; 45(1):92-8.
    View in: PubMed
    Score: 0.007
  174. Parkinsonian signs and incident falls in older persons without Parkinson's disease. J Am Geriatr Soc. 2010 Jan; 58(1):205-6.
    View in: PubMed
    Score: 0.007
  175. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol Aging. 2011 Oct; 32(10):1756-64.
    View in: PubMed
    Score: 0.007
  176. Pulmonary function, muscle strength, and incident mobility disability in elders. Proc Am Thorac Soc. 2009 Dec 01; 6(7):581-7.
    View in: PubMed
    Score: 0.007
  177. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun. 2010 Mar; 24(3):438-43.
    View in: PubMed
    Score: 0.007
  178. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.007
  179. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.007
  180. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.007
  181. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92.
    View in: PubMed
    Score: 0.007
  182. Association between late-life social activity and motor decline in older adults. Arch Intern Med. 2009 Jun 22; 169(12):1139-46.
    View in: PubMed
    Score: 0.007
  183. Vibratory thresholds and mobility in older persons. Muscle Nerve. 2009 Jun; 39(6):754-60.
    View in: PubMed
    Score: 0.007
  184. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord. 2009 May 15; 24(7):1070-3.
    View in: PubMed
    Score: 0.007
  185. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.007
  186. Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease? Clin Neurophysiol. 2009 Feb; 120(2):390-7.
    View in: PubMed
    Score: 0.006
  187. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2009 Jul; 15(6):471-4.
    View in: PubMed
    Score: 0.006
  188. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
    View in: PubMed
    Score: 0.006
  189. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.006
  190. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008 Aug 12; 71(7):499-504.
    View in: PubMed
    Score: 0.006
  191. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord. 2008 Jul 30; 23(10):1479-82.
    View in: PubMed
    Score: 0.006
  192. Resolving kinematic redundancy in target-reaching movements with and without external constraint. Exp Brain Res. 2008 Oct; 191(1):67-81.
    View in: PubMed
    Score: 0.006
  193. Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia. J Mot Behav. 2008 Jul; 40(4):301-13.
    View in: PubMed
    Score: 0.006
  194. Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry. 2008 Jun; 23(6):598-603.
    View in: PubMed
    Score: 0.006
  195. Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death. Pediatr Pulmonol. 2008 Jan; 43(1):77-86.
    View in: PubMed
    Score: 0.006
  196. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology. 2007 Mar 06; 68(10):757-63.
    View in: PubMed
    Score: 0.006
  197. Association of daytime napping and Parkinsonian signs in Alzheimer's disease. Sleep Med. 2006 Dec; 7(8):614-8.
    View in: PubMed
    Score: 0.006
  198. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):525-40.
    View in: PubMed
    Score: 0.006
  199. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Jun 27; 103(26):10041-5.
    View in: PubMed
    Score: 0.005
  200. The malignant course of "benign hallucinations" in Parkinson disease. Arch Neurol. 2006 May; 63(5):713-6.
    View in: PubMed
    Score: 0.005
  201. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Apr; 12(3):177-80.
    View in: PubMed
    Score: 0.005
  202. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology. 2005 Nov 08; 65(9):1423-9.
    View in: PubMed
    Score: 0.005
  203. Transcultural comparison of psychogenic movement disorders. Mov Disord. 2005 Oct; 20(10):1343-5.
    View in: PubMed
    Score: 0.005
  204. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.005
  205. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology. 2005 May 10; 64(9):1520-4.
    View in: PubMed
    Score: 0.005
  206. Focal neurological deficits and West Nile virus infection. Clin Infect Dis. 2005 Apr 01; 40(7):e59-62.
    View in: PubMed
    Score: 0.005
  207. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
    View in: PubMed
    Score: 0.005
  208. Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord. 2004 Dec; 10(8):507-10.
    View in: PubMed
    Score: 0.005
  209. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.005
  210. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Arch Neurol. 2004 Aug; 61(8):1280-4.
    View in: PubMed
    Score: 0.005
  211. Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. 2004 Oct; 13(6):516-23.
    View in: PubMed
    Score: 0.005
  212. Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology. 2004 Jan-Apr; 23(1-2):61-6.
    View in: PubMed
    Score: 0.005
  213. Dopaminergic hypersensitivity in patients with Parkinson disease and migraine. Clin Neuropharmacol. 2004 Jan-Feb; 27(1):30-2.
    View in: PubMed
    Score: 0.005
  214. Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord. 2003 Oct; 10(1):9-14.
    View in: PubMed
    Score: 0.005
  215. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA. 2003 Jun 11; 289(22):2947-57.
    View in: PubMed
    Score: 0.004
  216. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp Neurol. 2003 Jun; 181(2):213-23.
    View in: PubMed
    Score: 0.004
  217. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003 Apr; 60(4):529-33.
    View in: PubMed
    Score: 0.004
  218. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003 Mar 25; 60(6):917-22.
    View in: PubMed
    Score: 0.004
  219. Rating scales for dystonia: a multicenter assessment. Mov Disord. 2003 Mar; 18(3):303-312.
    View in: PubMed
    Score: 0.004
  220. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology. 2003 Jan 14; 60(1):64-8.
    View in: PubMed
    Score: 0.004
  221. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
    View in: PubMed
    Score: 0.004
  222. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002 Mar; 17(2):283-8.
    View in: PubMed
    Score: 0.004
  223. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.004
  224. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology. 2001 Dec 11; 57(11):2078-82.
    View in: PubMed
    Score: 0.004
  225. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol. 2001 Sep; 58(9):1379-82.
    View in: PubMed
    Score: 0.004
  226. A comparison of stroke risk factors in patients enrolled in stroke prevention trials. J Natl Med Assoc. 2001 Mar; 93(3):79-86.
    View in: PubMed
    Score: 0.004
  227. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001 Feb; 58(2):209-13.
    View in: PubMed
    Score: 0.004
  228. Effect of age and gender in the control of elbow flexion movements. J Mot Behav. 2000 Dec; 32(4):391-9.
    View in: PubMed
    Score: 0.004
  229. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3.
    View in: PubMed
    Score: 0.004
  230. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology. 2000 Sep 26; 55(6):789-94.
    View in: PubMed
    Score: 0.004
  231. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000 Mar; 15(2):276-9.
    View in: PubMed
    Score: 0.004
  232. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12.
    View in: PubMed
    Score: 0.004
  233. Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4.
    View in: PubMed
    Score: 0.004
  234. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62.
    View in: PubMed
    Score: 0.003
  235. Does adoption affect subsequent fertility? Am J Obstet Gynecol. 1979 May 15; 134(2):138-44.
    View in: PubMed
    Score: 0.003
  236. Does adoption affect subsequent fertility? Trans Pac Coast Obstet Gynecol Soc. 1979; 46:37-43.
    View in: PubMed
    Score: 0.003
  237. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21.
    View in: PubMed
    Score: 0.003
  238. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):289-95.
    View in: PubMed
    Score: 0.003
  239. Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope. 1998 May; 108(5):630-8.
    View in: PubMed
    Score: 0.003
  240. The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD). Mov Disord. 1998 May; 13(3):490-6.
    View in: PubMed
    Score: 0.003
  241. Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998 Jan; 124(1):80-5.
    View in: PubMed
    Score: 0.003
  242. Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation. Laryngoscope. 1997 Jun; 107(6):827-33.
    View in: PubMed
    Score: 0.003
  243. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum. 1996 Oct; 39(10):1073-80.
    View in: PubMed
    Score: 0.003
  244. Gait pattern in the early recovery period after stroke. J Bone Joint Surg Am. 1996 Oct; 78(10):1506-14.
    View in: PubMed
    Score: 0.003
  245. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg. 1995 Dec; 222(6):695-9.
    View in: PubMed
    Score: 0.003
  246. The childhood growth of twin children. Acta Genet Med Gemellol (Roma). 1995; 44(3-4):169-78.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.